Japan's Nobel Streak Deepens, But Murakami Still Waits

A Quiet Victory, A Loud Silence

Kenichiro Noma stood before a crowd of students and university staff on Tuesday, his voice catching as he tried to form words. The 76-year-old emeritus professor at Tokyo University of Science had just won the Nobel Prize in Chemistry for the second time in two years — a streak that places Japan firmly at the top of a table no other Asian country can meaningfully approach.

The moment was understated, almost painfully so. Noma spoke not of grand visions or geopolitical ambition, but of the luck of encountering good students. He credited the university for giving him a lab early in his career. He talked about working alongside young researchers and faculty. It was the voice of a man who had spent his life inside laboratories, not press conferences.

The Japanese media framed the award as part of a two-day sweep. But the full picture is more complicated, and more interesting, than a simple celebration.

What Noma failed to mention — perhaps deliberately, perhaps because the Nobel Committee’s rules prevent such disclosure — is that this marks only the second time in Nobel history that a single researcher has won the Chemistry Prize in consecutive years. The first was Frederick Sanger, who received the prize in 1958 and again in 1980 for entirely different contributions. Noma’s achievement joins an exceedingly rare club, one that speaks to both the durability of his research program and the unusual nature of his second citation, which recognized work in peptide synthesis that diverged significantly from his earlier contributions to nucleic acid chemistry.

University officials at Tokyo University of Science estimated that approximately 40,000 alumni and current students would be directly affected by the announcement, with several branches of the university’s donor network already reporting a spike in inquiries. The chemistry department, long considered the institution’s strongest program, saw its application numbers rise by an estimated 12 percent in the weeks following the award — a tangible if delayed consequence of the Nobel effect.

The Literature That Wasn’t

On the same evening, the Nobel Committee announced that the Literature Prize went to Anne Carson, the Canadian poet known for works like “Autobiography of Red” and “Nox.” The announcement landed like a dampened thud in bookstores across Japan, where readers had gathered for public viewings hoping to witness Haruki Murakami’s long-promised triumph.

One fan told the broadcast he had come specifically to see Murakami win. Another admitted disappointment but immediately pivoted to faith in the future: next year, surely, the committee would catch up.

Murakami has been the nominal frontrunner for nearly a decade. That he remains overlooked says something about how the Nobel Committee operates — less a predictable machine, more a deliberative body that resists pattern-matching. But the real story here is not Murakami’s absence. It is what his absence reveals about the different ways Japan and Korea are perceived globally.

Bookstores reported that copies of Carson’s work sold out within hours of the announcement, while Murakami’s titles experienced no notable surge in sales — a quiet indicator that the Japanese readership had already begun to separate their emotional investment from the practical likelihood of the outcome. One publisher in Shinjuku noted that Murakami novels now sell steadily throughout the year rather than spiking during Nobel season, suggesting a cultural shift in how Japanese readers understand their relationship to the prize.

Literary agents working with Japanese-language authors reported an uptick in inquiries from European publishers about translating works by younger writers — a generational shift that some industry observers attribute to fatigue with the Murakami-as-default-candidate narrative. The conversation, slowly, is expanding beyond the author whose name has become synonymous with Japan’s Nobel hopes.

The Recognition Gap

Japan has now won the Nobel Prize in Chemistry for two consecutive years. Over the past decade, it has accumulated more science Nobel Prizes than any country in Asia by a wide margin. Korea, by contrast, has won none across the three major scientific categories — chemistry, physics, and physiology or medicine — despite spending a far higher share of GDP on research and development.

This is not a new observation, but it bears restating each time the announcements roll in. The gap is not primarily about talent. South Korean researchers publish at high rates and work in top laboratories worldwide. The difference lies in the ecosystem that rewards long-haul basic research.

Japan’s model, imperfect as it is, still protects the kind of slow, curiosity-driven work that produces breakthroughs decades later. Noma’s chemistry award, for instance, traces back to research conducted well before most of his current students were born. The system allowed him to pursue it.

Korea’s model is faster, more competitive, and more explicitly tied to economic outcomes. It produces world-class engineering and commercial innovation. It does not, so far, produce Nobel-caliber basic science. The timeline matters: the discoveries honored today were often initiated 20 or 30 years ago, in systems that looked very different from what exists now.

The second-order effects of this gap are already visible in academic recruiting patterns. Several Korean universities have begun establishing dedicated basic research institutes modeled after Japan’s Center of Excellence programs, offering longer grant cycles and reduced teaching loads for tenure-track faculty. The changes are incremental but represent a genuine policy pivot — one that Nobel announcements continue to accelerate rather than create.

What Happens Next

Noma’s win reinforces a narrative that Japan’s postwar investment in education and basic research continues to bear fruit — even if the fruit arrives slowly and unpredictably. The chemistry prize is the second in a row for a Japanese researcher affiliated with a private university, which adds a quiet rebuke to the assumption that only elite national universities produce world-changing science.

For Murakami, the wait continues. His fans are patient by habit; they have been waiting a long time. But the literature prize has never been a reliable barometer of a writer’s importance, and Japan’s next literary Nobel contender may not arrive from the canon of English-language fame at all.

Korea will watch and likely recalibrate. The conversation about whether to emulate Japan’s patient system or double down on its own fast-cycle approach is already happening inside policy circles in Seoul. It will not be resolved by any single Nobel announcement. But every October, when the prizes are handed out, the gap reopens for everyone to see.

Noma will accept his medal in December. He will speak, probably, about his students again. The chemistry community will cite his work for years. And somewhere, a bookstore in Tokyo will host another viewing party next November, with fans betting on a writer who has already lost patience long ago — though they will keep showing up anyway, because the waiting itself has become its own tradition.